ABEONA THERAPEUTICS INC's ticker is ABEO and the CUSIP is 00289Y107. A total of 73 filers reported holding ABEONA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $87,000 | -54.7% | 11,860 | -2.0% | 0.00% | -20.0% |
| Q4 2017 | $192,000 | -64.9% | 12,108 | -62.3% | 0.01% | -64.3% |
| Q3 2017 | $547,000 | +225.6% | 32,108 | -4.2% | 0.01% | +180.0% |
| Q1 2017 | $168,000 | +3.7% | 33,500 | 0.0% | 0.01% | +25.0% |
| Q4 2016 | $162,000 | – | 33,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,359,767 | $11,445,000 | 20.08% |
| NEXTHERA CAPITAL LP | 568,573 | $2,758,000 | 1.62% |
| Kavi Asset Management, LP | 365,600 | $1,773,000 | 1.30% |
| Opaleye Management Inc. | 400,000 | $1,940,000 | 1.14% |
| RA Capital Management | 1,142,857 | $5,543,000 | 0.78% |
| Castle Hook Partners LP | 349,800 | $1,697,000 | 0.38% |
| Cormorant Asset Management, LP | 500,000 | $2,425,000 | 0.33% |
| DAFNA Capital Management LLC | 76,800 | $372,000 | 0.33% |
| Perceptive Advisors | 842,173 | $4,085,000 | 0.29% |
| Soros Fund Management | 896,642 | $4,349,000 | 0.10% |